🔎 Trials Near Me

Akèy › Limfom › Nebraska › Omaha

Etid klinik pou Limfom nan Omaha, NE

7 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Ap rekrite
  • University of Nebraska Medical Center, Omaha
Laj 19 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04898790

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Ap rekriteFaz 1
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • University of Nebraska Medical Center (UNMC), Omaha
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

Ap rekrite
  • Unversity of Nebraska Medical Center, Omaha
Laj 19 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05135351

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Ap rekriteFaz 1/2
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

Etid Limfom nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.